VIVLODEX®: A low-dose NSAID treatment option for patients with osteoarthritis pain

VIVLODEX®: The lowest FDA-approved dose of meloxicam available (5 mg)

VIVLODEX is a nonsteroidal anti-inflammatory drug (NSAID) for patients with osteoarthritis pain. Iroko Pharmaceuticals, LLC developed VIVLODEX to align with recommendations from FDA, medical organizations, and advocacy groups: Use the lowest NSAID dose possible for the shortest time needed for your treatment.

Why VIVLODEX®?

5 mg is the lowest FDA-approved dose of meloxicam available

VIVLODEX was created using SoluMatrix Fine Particle Technology, a technology that helps drugs dissolve quickly so they can be rapidly absorbed by the body

Low-dose SoluMatrix® NSAIDs were developed by Iroko to align with recommendations from FDA, medical organizations, and advocacy groups: Use the lowest dose possible for the shortest time needed for your treatment

Do you know your NSAID dose?

Ask your doctor if you are taking the lowest dose possible for the treatment of OA pain. Then ask about VIVLODEX, the low-dose SoluMatrix® meloxicam from Iroko.

Ask Your Doctor About VIVLODEX®

VIVLODEX®: Clinical study results in patients with osteoarthritis pain

In a clinical study, patients who took VIVLODEX 5 mg or 10 mg once daily:

Experienced greater reductions in osteoarthritis pain compared with patients who took placebo

Did better on measures of stiffness compared with patients who took placebo

Did better on measures of function compared with patients who took placebo

VIVLODEX®: Possible side effects

Before beginning treatment with VIVLODEX, it is important to be aware of potential side effects and to discuss these potential problems with your doctor

The most common side effects reported in clinical studies using VIVLODEX were:

  • Diarrhea
  • Nausea
  • Abdominal discomfort

VIVLODEX®: Dosing and administration

VIVLODEX is FDA approved at 5-mg and 10-mg doses administered once daily:

  • In a clinical study, VIVLODEX helped patients manage osteoarthritis pain at these low doses
  • 5 mg is the lowest FDA-approved dose of meloxicam available
  • For management of osteoarthritis pain, the recommended starting dosage is 5 mg orally once daily. Dose may be increased to 10 mg in patients who require additional analgesia. The maximum recommended daily oral dose of VIVLODEX is 10 mg

VIVLODEX was developed to align with recommendations from FDA, medical organizations, and advocacy groups: Use the lowest NSAID dose possible for the shortest time needed for your treatment.

Do you know your NSAID dose?

Ask your doctor if you are taking the lowest dose possible for the treatment of OA pain. Then ask about VIVLODEX, the low-dose SoluMatrix® meloxicam from Iroko.

Ask Your Doctor About VIVLODEX®

Eligible* patients
pay as little as
$10

*Terms and Conditions may apply.